The path forward for T cell engagers in patients with prostate cancer
AbstractT cell engagers (TCEs) recruit T cells to the tumor microenvironment (TME) to induce antitumor immune responses. TCEs have demonstrated promising clinical responses in patients with metastatic castration-resistant prostate cancer and have advanced into phase 3 clinical trials. Here we provid...
Na minha lista:
| Principais autores: | , , , , |
|---|---|
| 格式: | Artigo |
| 语言: | Inglês |
| 出版: |
BMJ Publishing Group
2026-02-01
|
| 丛编: | Journal for ImmunoTherapy of Cancer |
| 在线阅读: | https://jitc.bmj.com/content/14/2/e013905.full |
| 标签: |
没有标签, 成为第一个标记此记录!
|